| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | SSB9S6N20R |
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C19H20F3N3O3S |
| Molecular Weight | 427.45 |
| AlogP | 2.94 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 70.58 |
| Molecular species | None |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BLOCKER | Voltage-gated N-type calcium channel alpha-1B subunit blocker |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetic Neuropathies | 2 | D003929 | ClinicalTrials |
| Neuralgia, Postherpetic | 2 | D051474 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545172 |
| FDA SRS | SSB9S6N20R |
CONTENTS